388 related articles for article (PubMed ID: 31367976)
1. Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators.
Negi S; Rutman AK; Paraskevas S
Curr Diab Rep; 2019 Jul; 19(9):69. PubMed ID: 31367976
[TBL] [Abstract][Full Text] [Related]
2. Presence of diabetes autoantigens in extracellular vesicles derived from human islets.
Hasilo CP; Negi S; Allaeys I; Cloutier N; Rutman AK; Gasparrini M; Bonneil É; Thibault P; Boilard É; Paraskevas S
Sci Rep; 2017 Jul; 7(1):5000. PubMed ID: 28694505
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-to-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools.
Grieco GE; Fignani D; Formichi C; Nigi L; Licata G; Maccora C; Brusco N; Sebastiani G; Dotta F
Front Immunol; 2021; 12():682948. PubMed ID: 34177928
[TBL] [Abstract][Full Text] [Related]
4. Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction.
Peters L; Posgai A; Brusko TM
Clin Exp Immunol; 2019 Dec; 198(3):326-340. PubMed ID: 31309537
[TBL] [Abstract][Full Text] [Related]
5. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets.
Rodriguez-Calvo T; Johnson JD; Overbergh L; Dunne JL
Front Immunol; 2021; 12():667989. PubMed ID: 33953728
[TBL] [Abstract][Full Text] [Related]
6. Molecular and Functional Diversity of Distinct Subpopulations of the Stressed Insulin-Secreting Cell's Vesiculome.
Giri KR; de Beaurepaire L; Jegou D; Lavy M; Mosser M; Dupont A; Fleurisson R; Dubreil L; Collot M; Van Endert P; Bach JM; Mignot G; Bosch S
Front Immunol; 2020; 11():1814. PubMed ID: 33101266
[TBL] [Abstract][Full Text] [Related]
7. Advances in the etiology and mechanisms of type 1 diabetes.
Pugliese A
Discov Med; 2014 Sep; 18(98):141-50. PubMed ID: 25227755
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
9. Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus.
Garcia-Contreras M; Brooks RW; Boccuzzi L; Robbins PD; Ricordi C
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2940-2956. PubMed ID: 28682421
[TBL] [Abstract][Full Text] [Related]
10. Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes.
Hu W; Song X; Yu H; Sun J; Wang H; Zhao Y
Front Endocrinol (Lausanne); 2021; 12():682145. PubMed ID: 35095751
[TBL] [Abstract][Full Text] [Related]
11. Immune Response to Extracellular Vesicles From Human Islets of Langerhans in Patients With Type 1 Diabetes.
Rutman AK; Negi S; Gasparrini M; Hasilo CP; Tchervenkov J; Paraskevas S
Endocrinology; 2018 Nov; 159(11):3834-3847. PubMed ID: 30307543
[TBL] [Abstract][Full Text] [Related]
12. Antigen targets of type 1 diabetes autoimmunity.
Roep BO; Peakman M
Cold Spring Harb Perspect Med; 2012 Apr; 2(4):a007781. PubMed ID: 22474615
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles in β cell biology: Role of lipids in vesicle biogenesis, cargo, and intercellular signaling.
Aguirre RS; Kulkarni A; Becker MW; Lei X; Sarkar S; Ramanadham S; Phelps EA; Nakayasu ES; Sims EK; Mirmira RG
Mol Metab; 2022 Sep; 63():101545. PubMed ID: 35817393
[TBL] [Abstract][Full Text] [Related]
14. The role of T cell miRNAs for regulatory T cell induction in islet autoimmunity.
Scherm MG; Serr I; Kaestner KH; Daniel C
Mol Metab; 2019 Sep; 27S(Suppl):S122-S128. PubMed ID: 31500823
[TBL] [Abstract][Full Text] [Related]
15. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
[TBL] [Abstract][Full Text] [Related]
16. A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes.
Roep BO; Kracht MJ; van Lummel M; Zaldumbide A
Curr Opin Immunol; 2016 Dec; 43():67-73. PubMed ID: 27723537
[TBL] [Abstract][Full Text] [Related]
17. Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes.
Lakhter AJ; Pratt RE; Moore RE; Doucette KK; Maier BF; DiMeglio LA; Sims EK
Diabetologia; 2018 May; 61(5):1124-1134. PubMed ID: 29445851
[TBL] [Abstract][Full Text] [Related]
18. Islet Autoantibodies.
Lampasona V; Liberati D
Curr Diab Rep; 2016 Jun; 16(6):53. PubMed ID: 27112957
[TBL] [Abstract][Full Text] [Related]
19. The Role of Extracellular Vesicles in β-Cell Function and Viability: A Scoping Review.
Chidester S; Livinski AA; Fish AF; Joseph PV
Front Endocrinol (Lausanne); 2020; 11():375. PubMed ID: 32595604
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.
Allen JS; Pang K; Skowera A; Ellis R; Rackham C; Lozanoska-Ochser B; Tree T; Leslie RD; Tremble JM; Dayan CM; Peakman M
Diabetes; 2009 Jan; 58(1):138-45. PubMed ID: 18835928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
